BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:BLCO - CA0717051076 - Common Stock
16.98 USD
-0.11 (-0.64%)
16.98 USD
0 (0%)
Overall BLCO gets a fundamental rating of 2 out of 10. We evaluated BLCO against 187 industry peers in the Health Care Equipment & Supplies industry. BLCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLCO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BLCO had positive earnings in the past year.
In the past year BLCO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
BLCO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BLCO has a better Return On Assets (-2.21%) than 70.05% of its industry peers.
BLCO has a Return On Equity of -4.74%. This is in the better half of the industry: BLCO outperforms 70.59% of its industry peers.
The Return On Invested Capital of BLCO (0.76%) is better than 66.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLCO is significantly below the industry average of 8.82%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROIC | 0.76% |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
1.3 Margins
With a decent Operating Margin value of 2.31%, BLCO is doing good in the industry, outperforming 67.91% of the companies in the same industry.
In the last couple of years the Operating Margin of BLCO has declined.
The Gross Margin of BLCO (59.45%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.31% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% |
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
BLCO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BLCO has more shares outstanding
The debt/assets ratio for BLCO is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.87, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
BLCO has a Altman-Z score of 0.87. This is comparable to the rest of the industry: BLCO outperforms 50.27% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that BLCO is somewhat dependend on debt financing.
BLCO's Debt to Equity ratio of 0.77 is on the low side compared to the rest of the industry. BLCO is outperformed by 68.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.87 |
ROIC/WACC0.1
WACC7.44%
2.3 Liquidity
A Current Ratio of 1.51 indicates that BLCO should not have too much problems paying its short term obligations.
BLCO has a Current ratio of 1.51. This is in the lower half of the industry: BLCO underperforms 74.87% of its industry peers.
A Quick Ratio of 0.98 indicates that BLCO may have some problems paying its short term obligations.
BLCO has a worse Quick ratio (0.98) than 77.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The earnings per share for BLCO have decreased strongly by -29.51% in the last year.
Looking at the last year, BLCO shows a small growth in Revenue. The Revenue has grown by 6.23% in the last year.
The Revenue has been growing slightly by 4.87% on average over the past years.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
3.2 Future
The Earnings Per Share is expected to grow by 22.03% on average over the next years. This is a very strong growth
BLCO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.98% yearly.
EPS Next Y-10.98%
EPS Next 2Y13.01%
EPS Next 3Y18.15%
EPS Next 5Y22.03%
Revenue Next Year6.48%
Revenue Next 2Y6.13%
Revenue Next 3Y5.84%
Revenue Next 5Y4.98%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 39.49 indicates a quite expensive valuation of BLCO.
Compared to the rest of the industry, the Price/Earnings ratio of BLCO indicates a somewhat cheap valuation: BLCO is cheaper than 70.05% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BLCO to the average of the S&P500 Index (26.43), we can say BLCO is valued slightly more expensively.
A Price/Forward Earnings ratio of 21.44 indicates a rather expensive valuation of BLCO.
79.68% of the companies in the same industry are more expensive than BLCO, based on the Price/Forward Earnings ratio.
BLCO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.66, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.49 | ||
| Fwd PE | 21.44 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BLCO is valued a bit cheaper than 77.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 19.69 |
4.3 Compensation for Growth
A more expensive valuation may be justified as BLCO's earnings are expected to grow with 18.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.01%
EPS Next 3Y18.15%
5. Dividend
5.1 Amount
No dividends for BLCO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
16.98
-0.11 (-0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners11.05%
Inst Owner Change7.26%
Ins Owners0.45%
Ins Owner Change2.16%
Market Cap6.01B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72
Price Target17.5 (3.06%)
Short Float %8.47%
Short Ratio7.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.41%
PT rev (3m)11.59%
EPS NQ rev (1m)-1.56%
EPS NQ rev (3m)-3.42%
EPS NY rev (1m)0.68%
EPS NY rev (3m)1.78%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.49 | ||
| Fwd PE | 21.44 | ||
| P/S | 1.21 | ||
| P/FCF | N/A | ||
| P/OCF | 35.59 | ||
| P/B | 0.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.69 |
EPS(TTM)0.43
EY2.53%
EPS(NY)0.79
Fwd EY4.66%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.48
OCFY2.81%
SpS14.05
BVpS18.15
TBVpS-4.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROCE | 0.96% | ||
| ROIC | 0.76% | ||
| ROICexc | 0.78% | ||
| ROICexgc | 2.5% | ||
| OM | 2.31% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% | ||
| FCFM | N/A |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
ROICexc(3y)1.64%
ROICexc(5y)1.97%
ROICexgc(3y)5.47%
ROICexgc(5y)6.76%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.06 | ||
| Cap/Depr | 85.28% | ||
| Cap/Sales | 7.34% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 31.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.87 |
F-Score4
WACC7.44%
ROIC/WACC0.1
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-10.98%
EPS Next 2Y13.01%
EPS Next 3Y18.15%
EPS Next 5Y22.03%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.48%
Revenue Next 2Y6.13%
Revenue Next 3Y5.84%
Revenue Next 5Y4.98%
EBIT growth 1Y-39.47%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year46.38%
EBIT Next 3Y23.01%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%
BAUSCH + LOMB CORP / BLCO FAQ
What is the fundamental rating for BLCO stock?
ChartMill assigns a fundamental rating of 2 / 10 to BLCO.
What is the valuation status for BLCO stock?
ChartMill assigns a valuation rating of 2 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Overvalued.
Can you provide the profitability details for BAUSCH + LOMB CORP?
BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.
What is the valuation of BAUSCH + LOMB CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BAUSCH + LOMB CORP (BLCO) is 39.49 and the Price/Book (PB) ratio is 0.94.
Can you provide the financial health for BLCO stock?
The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.